Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Increased circulating of myeloid-derived suppressor cells in myelodysplastic syndrome.

Literature DB >> 23823840

Increased circulating of myeloid-derived suppressor cells in myelodysplastic syndrome.

Hui-juan Jiang¹, Rong Fu, Hua-quan Wang, Li-juan Li, Wen Qu, Yong Liang, Guo-jin Wang, Xiao-ming Wang, Yu-Hong Wu, Hong Liu, Jia Song, Jing Guan, Li-Min Xing, Er-Bao Ruan, Zong-Hong Shao.

Abstract

Entities: Disease

Mesh：

Year: 2013 PMID： 23823840

Source DB: PubMed Journal: Chin Med J (Engl) ISSN： 0366-6999 Impact factor: 2.628

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Immune Dysregulation and Recurring Mutations in Myelodysplastic Syndromes Pathogenesis.

Authors: Anacélia Matos; Silvia M M Magalhães; Michael J Rauh
Journal: Adv Exp Med Biol Date: 2021 Impact factor: 2.622

Review 2. Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Authors: Georgios Petros Barakos; Eleftheria Hatzimichael
Journal: Diseases Date: 2022-06-10

3. Gut Microbiome and Plasma Metabolomic Analysis in Patients with Myelodysplastic Syndrome.

Authors: Huijuan Jiang; Xiaoyu Zhao; Mengtong Zang; Rong Fu; Zonghong Shao; Chunyan Liu
Journal: Oxid Med Cell Longev Date: 2022-05-09 Impact factor: 7.310

Review 4. The Rising Era of Immune Checkpoint Inhibitors in Myelodysplastic Syndromes.

Authors: Nora Chokr; Rima Patel; Kapil Wattamwar; Samer Chokr
Journal: Adv Hematol Date: 2018-11-01

5. Increased Circulating of CD54^highCD181^low Neutrophils in Myelodysplastic Syndrome.

Authors: Liyan Yang; Hongzhao Li; Yumei Liu; Xinyan Xie; Huiqin Zhang; Haiyue Niu; Zonghong Shao; Limin Xing; Huaquan Wang
Journal: Front Oncol Date: 2021-01-11 Impact factor: 6.244

6. [The expression and prognostic value of PD-1, TIM-3, LAG-3 and BTLA in extranodal NK/T cell lymphoma].

Authors: L Nie; X Y Liu; R J Ma; X L Yuan; L Jiang; J Yang; A X Hu; Z Li; Z M Zhu
Journal: Zhonghua Xue Ye Xue Za Zhi Date: 2021-07-14

7. Increased Circulating CD4⁺CXCR5⁺ Cells and IgG4 Levels in Patients with Myelodysplastic Syndrome with Autoimmune Diseases.

Authors: Na Xiao; Xin He; Haiyue Niu; Hong Yu; Ningbo Cui; Hongzhao Li; Li Yan; Zonghong Shao; Limin Xing; Huaquan Wang
Journal: J Immunol Res Date: 2021-09-30 Impact factor: 4.818

Increased circulating of myeloid-derived suppressor cells in myelodysplastic syndrome.

1. Immune Dysregulation and Recurring Mutations in Myelodysplastic Syndromes Pathogenesis.

Review 2. Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia.

3. Gut Microbiome and Plasma Metabolomic Analysis in Patients with Myelodysplastic Syndrome.

Review 4. The Rising Era of Immune Checkpoint Inhibitors in Myelodysplastic Syndromes.

5. Increased Circulating of CD54^highCD181^low Neutrophils in Myelodysplastic Syndrome.

6. [The expression and prognostic value of PD-1, TIM-3, LAG-3 and BTLA in extranodal NK/T cell lymphoma].

7. Increased Circulating CD4⁺CXCR5⁺ Cells and IgG4 Levels in Patients with Myelodysplastic Syndrome with Autoimmune Diseases.

Review 8. Myeloid-Derived Suppressor Cells: New Insights into the Pathogenesis and Therapy of MDS.

Review 9. The yin-yang of immunity: Immune dysregulation in myelodysplastic syndrome with different risk stratification.

10. Immunological derangement in hypocellular myelodysplastic syndromes.

Increased circulating of myeloid-derived suppressor cells in myelodysplastic syndrome.

1. Immune Dysregulation and Recurring Mutations in Myelodysplastic Syndromes Pathogenesis.

Review 2. Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia.

3. Gut Microbiome and Plasma Metabolomic Analysis in Patients with Myelodysplastic Syndrome.

Review 4. The Rising Era of Immune Checkpoint Inhibitors in Myelodysplastic Syndromes.

5. Increased Circulating of CD54highCD181low Neutrophils in Myelodysplastic Syndrome.

6. [The expression and prognostic value of PD-1, TIM-3, LAG-3 and BTLA in extranodal NK/T cell lymphoma].

7. Increased Circulating CD4+CXCR5+ Cells and IgG4 Levels in Patients with Myelodysplastic Syndrome with Autoimmune Diseases.

Review 8. Myeloid-Derived Suppressor Cells: New Insights into the Pathogenesis and Therapy of MDS.

Review 9. The yin-yang of immunity: Immune dysregulation in myelodysplastic syndrome with different risk stratification.

10. Immunological derangement in hypocellular myelodysplastic syndromes.

5. Increased Circulating of CD54^highCD181^low Neutrophils in Myelodysplastic Syndrome.

7. Increased Circulating CD4⁺CXCR5⁺ Cells and IgG4 Levels in Patients with Myelodysplastic Syndrome with Autoimmune Diseases.